Since many of these studies are performed in the absence of CD8+ T cells and even other types of immune cells, it has been long believed that B7‐H3 may exhibit immune cell‐independent functions to intrinsically enhance cancer cell growth, drug resistance, epithelial‐mesenchymal transition, and maintenance of stemness across different cancer types. Here, CD8A is linked to cancer.